latest health care news

24.08.20

Landmark NHS cystic fibrosis drug deal comes into effect

From today, thousands of NHS cystic fibrosis patients in England will have access to a ‘transformative’ treatment for the condition, benefiting from a landmark deal struck by NHS England last month.

NHS patients will become some of the first in Europe to be able to receive the ‘triple combination therapy’ treatment, which has shown to significantly improve lung function, helping people with cystic fibrosis breathe more easily, enhancing their overall quality of life.

European regulators gave the treatment the green light, setting live the previously struck deal with NHS England to get the drug out and available to patients as soon as it was licensed.

The treatment has been described as having shown evidence of being ‘truly life-transforming’ by the UK Cystic Fibrosis Medical Association.

More than 7,000 people with cystic fibrosis in England are likely to benefit from the therapy.

As part of the commercial deal struck by NHS England, equivalent terms were also secured for cystic fibrosis patients in Wales, Northern Ireland and Scotland – paving the way to full UK-wide access.

NHS National Medical Director Professor Stephen Powis, said: “At the same time as staff came together to put in a herculean effort to treat over 108,000 for coronavirus in hospitals, they also continued providing round the clock care for patients with long term conditions such as cystic fibrosis, and this landmark deal has put NHS patients at the front of the queue for transformational treatment.

“The NHS has developed world-leading commercial capabilities, enabling us to strike such landmark deals with the pharmaceutical industry and support people with cystic fibrosis to lead longer, healthier, better quality lives.”

The terms of the deal landed by NHS England also mean that as many as 300 patients with some rarer genetic mutations, which fall outside of the scope of the European licensing body’s considerations, will also now be able to benefit from other pharmaceutical drugs produced by the same supplier, offering a potential lifeline to some of those with limited treatment options.

Comments

There are no comments. Why not be the first?

Add your comment

 

national health executive tv

more videos >

featured articles

View all News

last word

Haseeb Ahmad: ‘We all have a role to play in getting innovations quicker’

Haseeb Ahmad: ‘We all have a role to play in getting innovations quicker’

Haseeb Ahmad, president of the Association of the British Pharmaceutical Industry (ABPI), sits down with National Health Executive as part of our Last Word Q&A series. Would you talk us throu more > more last word articles >

health service focus

View all News

comment

NHS England dementia director prescribes rugby for mental health and dementia patients

23/09/2019NHS England dementia director prescribes rugby for mental health and dementia patients

Reason to celebrate as NHS says watching rugby can be good for your mental ... more >
Peter Kyle MP: It’s time to say thank you this Public Service Day

21/06/2019Peter Kyle MP: It’s time to say thank you this Public Service Day

Taking time to say thank you is one of the hidden pillars of a society. Bei... more >

interviews

Organ Donation Week: Having the conversation

11/09/2020Organ Donation Week: Having the conversation

As part of Organ Donation Week, NHE’s Matt Roberts spoke with our Man... more >

the scalpel's daily blog

NICE’s support for rebuilding capacity in non-Covid health services

18/09/2020NICE’s support for rebuilding capacity in non-Covid health services

Paul Chrisp, Director of the Centre for Guidelines, NICE When the Covid-19 pandemic hit the UK’s shores earlier this year, the NHS responded quickly, diverting and ... more >
read more blog posts from 'the scalpel' >